Shenkier T - Search Results

1

A perspective on adverse health outcomes after breast cancer treatment in women with spinal cord injury.

Sawatzky B, Edwards CM, Walters-Shumka AT, Standfield S, Shenkier T, Harris SR. Sawatzky B, et al. Among authors: shenkier t. Spinal Cord. 2021 Jun;59(6):700-704. doi: 10.1038/s41393-021-00628-2. Epub 2021 Apr 7. Spinal Cord. 2021. PMID: 33828245 Review.

2

Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.

Bland KA, Kirkham AA, Bovard J, Shenkier T, Zucker D, McKenzie DC, Davis MK, Gelmon KA, Campbell KL. Bland KA, et al. Among authors: shenkier t. Clin Breast Cancer. 2019 Dec;19(6):411-422. doi: 10.1016/j.clbc.2019.05.013. Epub 2019 Jun 27. Clin Breast Cancer. 2019. PMID: 31601479 Clinical Trial.

3

A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer.

Gelmon KA, Tolcher A, O'Reilly S, Campbell C, Bryce C, Shenkier T, Ragaz J, Ayers D, Nakashima L, Rielly S, Dulude H. Gelmon KA, et al. Among authors: shenkier t. Ann Oncol. 1998 Nov;9(11):1247-9. doi: 10.1023/a:1008445123416. Ann Oncol. 1998. PMID: 9862057 Free article. Clinical Trial.

4

Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer.

Shenkier T, Weir L, Levine M, Olivotto I, Whelan T, Reyno L; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Shenkier T, et al. CMAJ. 2004 Mar 16;170(6):983-94. doi: 10.1503/cmaj.1030944. CMAJ. 2004. PMID: 15023926 Free PMC article. Review.

5

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.

Davidson JA, Cromwell I, Ellard SL, Lohrisch C, Gelmon KA, Shenkier T, Villa D, Lim H, Sun S, Taylor S, Taylor M, Czerkawski B, Hayes M, Ionescu DN, Yoshizawa C, Chao C, Peacock S, Chia SK. Davidson JA, et al. Among authors: shenkier t. Eur J Cancer. 2013 Jul;49(11):2469-75. doi: 10.1016/j.ejca.2013.03.009. Epub 2013 Apr 20. Eur J Cancer. 2013. PMID: 23611660

6

Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.

Zhao EY, Shen Y, Pleasance E, Kasaian K, Leelakumari S, Jones M, Bose P, Ch'ng C, Reisle C, Eirew P, Corbett R, Mungall KL, Thiessen N, Ma Y, Schein JE, Mungall AJ, Zhao Y, Moore RA, Den Brok W, Wilson S, Villa D, Shenkier T, Lohrisch C, Chia S, Yip S, Gelmon K, Lim H, Renouf D, Sun S, Schrader KA, Young S, Bosdet I, Karsan A, Laskin J, Marra MA, Jones SJM. Zhao EY, et al. Among authors: shenkier t. Clin Cancer Res. 2017 Dec 15;23(24):7521-7530. doi: 10.1158/1078-0432.CCR-17-1941. Clin Cancer Res. 2017. PMID: 29246904

7

Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis.

Panades M, Olivotto IA, Speers CH, Shenkier T, Olivotto TA, Weir L, Allan SJ, Truong PT. Panades M, et al. Among authors: shenkier t. J Clin Oncol. 2005 Mar 20;23(9):1941-50. doi: 10.1200/JCO.2005.06.233. J Clin Oncol. 2005. PMID: 15774787

8

A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers.

Yerushalmi R, Hayes MM, Gelmon KA, Chia S, Bajdik C, Norris B, Speers C, Hassell P, O'Reilly SE, Allan S, Shenkier TN. Yerushalmi R, et al. Clin Breast Cancer. 2009 Aug;9(3):166-72. doi: 10.3816/CBC.2009.n.027. Clin Breast Cancer. 2009. PMID: 19661040 Clinical Trial.

9

Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.

LeVasseur N, Sun J, Fenton D, Baxter S, Chan A, Roberts S, Feng X, Lohrisch C, Gelmon K, Shenkier T, Chia SK. LeVasseur N, et al. Among authors: shenkier t. Clin Breast Cancer. 2022 Jan;22(1):e74-e79. doi: 10.1016/j.clbc.2021.09.004. Epub 2021 Sep 17. Clin Breast Cancer. 2022. PMID: 34690081

10

Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia.

Lee B, Goktepe O, Hay K, Connors JM, Sehn LH, Savage KJ, Shenkier T, Klasa R, Gerrie A, Villa D. Lee B, et al. Among authors: shenkier t. Oncologist. 2014 Mar;19(3):283-90. doi: 10.1634/theoncologist.2013-0343. Epub 2014 Feb 25. Oncologist. 2014. PMID: 24569946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters